Global Pharmaceuticals for Women's Health Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Oral
  • 1.2.3 Topical
• 1.3 Market by Application
  • 1.3.1 Global Pharmaceuticals for Women's Health Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Postmenopausal Osteoporosis
  • 1.3.3 Endometriosis
  • 1.3.4 Polycystic Ovarian Syndrome
  • 1.3.5 Pregnancy Disorders
  • 1.3.6 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmaceuticals for Women's Health Market Perspective (2020-2031)
• 2.2 Global Pharmaceuticals for Women's Health Growth Trends by Region
  • 2.2.1 Global Pharmaceuticals for Women's Health Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Pharmaceuticals for Women's Health Market Size by Region (2020-2031)
• 2.3 Pharmaceuticals for Women's Health Market Dynamics
  • 2.3.1 Pharmaceuticals for Women's Health Industry Trends
  • 2.3.2 Pharmaceuticals for Women's Health Market Drivers
  • 2.3.3 Pharmaceuticals for Women's Health Market Challenges
  • 2.3.4 Pharmaceuticals for Women's Health Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Pharmaceuticals for Women's Health by Players
  • 3.1.1 Global Pharmaceuticals for Women's Health Revenue by Players (2020-2025)
  • 3.1.2 Global Pharmaceuticals for Women's Health Revenue Market Share by Players (2020-2025)
• 3.2 Global Pharmaceuticals for Women's Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Pharmaceuticals for Women's Health, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global Pharmaceuticals for Women's Health Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals for Women's Health Revenue in 2024
• 3.5 Global Key Players of Pharmaceuticals for Women's Health Head office and Area Served
• 3.6 Global Key Players of Pharmaceuticals for Women's Health, Product and Application
• 3.7 Global Key Players of Pharmaceuticals for Women's Health, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Pharmaceuticals for Women's Health Historic Market Size by Type (2020-2025)
• 4.2 Global Pharmaceuticals for Women's Health Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global Pharmaceuticals for Women's Health Historic Market Size by Application (2020-2025)
• 5.2 Global Pharmaceuticals for Women's Health Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America Pharmaceuticals for Women's Health Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America Pharmaceuticals for Women's Health Market Size by Type (2020-2031)
  • 6.2.2 North America Pharmaceuticals for Women's Health Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America Pharmaceuticals for Women's Health Market Size by Application (2020-2031)
  • 6.3.2 North America Pharmaceuticals for Women's Health Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America Pharmaceuticals for Women's Health Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America Pharmaceuticals for Women's Health Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Pharmaceuticals for Women's Health Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe Pharmaceuticals for Women's Health Market Size by Type (2020-2031)
  • 7.2.2 Europe Pharmaceuticals for Women's Health Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe Pharmaceuticals for Women's Health Market Size by Application (2020-2031)
  • 7.3.2 Europe Pharmaceuticals for Women's Health Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe Pharmaceuticals for Women's Health Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe Pharmaceuticals for Women's Health Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Pharmaceuticals for Women's Health Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China Pharmaceuticals for Women's Health Market Size by Type (2020-2031)
  • 8.2.2 China Pharmaceuticals for Women's Health Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China Pharmaceuticals for Women's Health Market Size by Application (2020-2031)
  • 8.3.2 China Pharmaceuticals for Women's Health Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Pharmaceuticals for Women's Health Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia Pharmaceuticals for Women's Health Market Size by Type (2020-2031)
  • 9.2.2 Asia Pharmaceuticals for Women's Health Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia Pharmaceuticals for Women's Health Market Size by Application (2020-2031)
  • 9.3.2 Asia Pharmaceuticals for Women's Health Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia Pharmaceuticals for Women's Health Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia Pharmaceuticals for Women's Health Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 Amgen
  • 11.1.1 Amgen Company Details
  • 11.1.2 Amgen Business Overview
  • 11.1.3 Amgen Pharmaceuticals for Women's Health Introduction
  • 11.1.4 Amgen Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.1.5 Amgen Recent Development
• 11.2 Bayer
  • 11.2.1 Bayer Company Details
  • 11.2.2 Bayer Business Overview
  • 11.2.3 Bayer Pharmaceuticals for Women's Health Introduction
  • 11.2.4 Bayer Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.2.5 Bayer Recent Development
• 11.3 Merck KGaA
  • 11.3.1 Merck KGaA Company Details
  • 11.3.2 Merck KGaA Business Overview
  • 11.3.3 Merck KGaA Pharmaceuticals for Women's Health Introduction
  • 11.3.4 Merck KGaA Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.3.5 Merck KGaA Recent Development
• 11.4 Merck & Co
  • 11.4.1 Merck & Co Company Details
  • 11.4.2 Merck & Co Business Overview
  • 11.4.3 Merck & Co Pharmaceuticals for Women's Health Introduction
  • 11.4.4 Merck & Co Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.4.5 Merck & Co Recent Development
• 11.5 Ferring
  • 11.5.1 Ferring Company Details
  • 11.5.2 Ferring Business Overview
  • 11.5.3 Ferring Pharmaceuticals for Women's Health Introduction
  • 11.5.4 Ferring Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.5.5 Ferring Recent Development
• 11.6 Eli Lilly
  • 11.6.1 Eli Lilly Company Details
  • 11.6.2 Eli Lilly Business Overview
  • 11.6.3 Eli Lilly Pharmaceuticals for Women's Health Introduction
  • 11.6.4 Eli Lilly Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.6.5 Eli Lilly Recent Development
• 11.7 Pfizer
  • 11.7.1 Pfizer Company Details
  • 11.7.2 Pfizer Business Overview
  • 11.7.3 Pfizer Pharmaceuticals for Women's Health Introduction
  • 11.7.4 Pfizer Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.7.5 Pfizer Recent Development
• 11.8 AbbVie
  • 11.8.1 AbbVie Company Details
  • 11.8.2 AbbVie Business Overview
  • 11.8.3 AbbVie Pharmaceuticals for Women's Health Introduction
  • 11.8.4 AbbVie Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.8.5 AbbVie Recent Development
• 11.9 Abbott
  • 11.9.1 Abbott Company Details
  • 11.9.2 Abbott Business Overview
  • 11.9.3 Abbott Pharmaceuticals for Women's Health Introduction
  • 11.9.4 Abbott Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.9.5 Abbott Recent Development
• 11.10 Theramex
  • 11.10.1 Theramex Company Details
  • 11.10.2 Theramex Business Overview
  • 11.10.3 Theramex Pharmaceuticals for Women's Health Introduction
  • 11.10.4 Theramex Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.10.5 Theramex Recent Development
• 11.11 Livzon Pharmaceuticals
  • 11.11.1 Livzon Pharmaceuticals Company Details
  • 11.11.2 Livzon Pharmaceuticals Business Overview
  • 11.11.3 Livzon Pharmaceuticals Pharmaceuticals for Women's Health Introduction
  • 11.11.4 Livzon Pharmaceuticals Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.11.5 Livzon Pharmaceuticals Recent Development
• 11.12 Foundation Consumer Healthcare
  • 11.12.1 Foundation Consumer Healthcare Company Details
  • 11.12.2 Foundation Consumer Healthcare Business Overview
  • 11.12.3 Foundation Consumer Healthcare Pharmaceuticals for Women's Health Introduction
  • 11.12.4 Foundation Consumer Healthcare Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.12.5 Foundation Consumer Healthcare Recent Development
• 11.13 Xianjun Pharmaceuticals
  • 11.13.1 Xianjun Pharmaceuticals Company Details
  • 11.13.2 Xianjun Pharmaceuticals Business Overview
  • 11.13.3 Xianjun Pharmaceuticals Pharmaceuticals for Women's Health Introduction
  • 11.13.4 Xianjun Pharmaceuticals Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.13.5 Xianjun Pharmaceuticals Recent Development
• 11.14 Zizhu Pharmaceuticals
  • 11.14.1 Zizhu Pharmaceuticals Company Details
  • 11.14.2 Zizhu Pharmaceuticals Business Overview
  • 11.14.3 Zizhu Pharmaceuticals Pharmaceuticals for Women's Health Introduction
  • 11.14.4 Zizhu Pharmaceuticals Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.14.5 Zizhu Pharmaceuticals Recent Development
• 11.15 Qianjin Pharmaceuticals
  • 11.15.1 Qianjin Pharmaceuticals Company Details
  • 11.15.2 Qianjin Pharmaceuticals Business Overview
  • 11.15.3 Qianjin Pharmaceuticals Pharmaceuticals for Women's Health Introduction
  • 11.15.4 Qianjin Pharmaceuticals Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.15.5 Qianjin Pharmaceuticals Recent Development
• 11.16 Organon Pharma
  • 11.16.1 Organon Pharma Company Details
  • 11.16.2 Organon Pharma Business Overview
  • 11.16.3 Organon Pharma Pharmaceuticals for Women's Health Introduction
  • 11.16.4 Organon Pharma Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.16.5 Organon Pharma Recent Development
• 11.17 Insud Pharma
  • 11.17.1 Insud Pharma Company Details
  • 11.17.2 Insud Pharma Business Overview
  • 11.17.3 Insud Pharma Pharmaceuticals for Women's Health Introduction
  • 11.17.4 Insud Pharma Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.17.5 Insud Pharma Recent Development
• 11.18 Viatris
  • 11.18.1 Viatris Company Details
  • 11.18.2 Viatris Business Overview
  • 11.18.3 Viatris Pharmaceuticals for Women's Health Introduction
  • 11.18.4 Viatris Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.18.5 Viatris Recent Development
• 11.19 Teva
  • 11.19.1 Teva Company Details
  • 11.19.2 Teva Business Overview
  • 11.19.3 Teva Pharmaceuticals for Women's Health Introduction
  • 11.19.4 Teva Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.19.5 Teva Recent Development
• 11.20 Hisamitsu
  • 11.20.1 Hisamitsu Company Details
  • 11.20.2 Hisamitsu Business Overview
  • 11.20.3 Hisamitsu Pharmaceuticals for Women's Health Introduction
  • 11.20.4 Hisamitsu Revenue in Pharmaceuticals for Women's Health Business (2020-2025)
  • 11.20.5 Hisamitsu Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Topical

Table 4. Global Pharmaceuticals for Women's Health Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Pharmaceuticals for Women's Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Market Size by Region (2020-2031) & (US$ Million)

Table 7. Global Pharmaceuticals for Women's Health Market Share by Region (2020-2031)

Table 8. Market Trends

Table 9. Market Drivers

Table 10. Market Challenges

Table 11. Market Restraints

Table 12. Global Pharmaceuticals for Women's Health Revenue by Players (2020-2025) & (US$ Million)

Table 13. Global Pharmaceuticals for Women's Health Market Share by Players (2020-2025)

Table 14. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals for Women's Health as of 2024)

Table 15. Global Pharmaceuticals for Women's Health Industry Ranking 2023 VS 2024

Table 16. Global 5 Largest Players Market Share by Pharmaceuticals for Women's Health Revenue (CR5 and HHI) & (2020-2025)

Table 17. Global Key Players of Pharmaceuticals for Women's Health, Headquarters and Area Served

Table 18. Global Key Players of Pharmaceuticals for Women's Health, Product and Application

Table 19. Global Key Players of Pharmaceuticals for Women's Health, Date of Enter into This Industry

Table 20. Mergers & Acquisitions, Expansion Plans

Table 21. Global Market Size by Type (2020-2025) & (US$ Million)

Table 22. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2020-2025)

Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 24. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2026-2031)

Table 25. Global Market Size by Application (2020-2025) & (US$ Million)

Table 26. Global Pharmaceuticals for Women's Health Revenue Market Share by Application (2020-2025)

Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 28. Global Pharmaceuticals for Women's Health Revenue Market Share by Application (2026-2031)

Table 29. North America Market Size by Type (2020-2031) & (US$ Million)

Table 30. North America Market Size by Application (2020-2031) & (US$ Million)

Table 31. North America Pharmaceuticals for Women's Health Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Market Size by Country (2020-2031) & (US$ Million)

Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 35. Europe Pharmaceuticals for Women's Health Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 37. China Market Size by Type (2020-2031) & (US$ Million)

Table 38. China Market Size by Application (2020-2031) & (US$ Million)

Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 41. Asia Pharmaceuticals for Women's Health Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 47. Amgen Company Details

Table 48. Amgen Business Overview

Table 49. Amgen Pharmaceuticals for Women's Health Product

Table 50. Amgen Revenue (2020-2025) & (US$ Million)

Table 51. Amgen Recent Development

Table 52. Bayer Company Details

Table 53. Bayer Business Overview

Table 54. Bayer Pharmaceuticals for Women's Health Product

Table 55. Bayer Revenue (2020-2025) & (US$ Million)

Table 56. Bayer Recent Development

Table 57. Merck KGaA Company Details

Table 58. Merck KGaA Business Overview

Table 59. Merck KGaA Pharmaceuticals for Women's Health Product

Table 60. Merck KGaA Revenue (2020-2025) & (US$ Million)

Table 61. Merck KGaA Recent Development

Table 62. Merck & Co Company Details

Table 63. Merck & Co Business Overview

Table 64. Merck & Co Pharmaceuticals for Women's Health Product

Table 65. Merck & Co Revenue (2020-2025) & (US$ Million)

Table 66. Merck & Co Recent Development

Table 67. Ferring Company Details

Table 68. Ferring Business Overview

Table 69. Ferring Pharmaceuticals for Women's Health Product

Table 70. Ferring Revenue (2020-2025) & (US$ Million)

Table 71. Ferring Recent Development

Table 72. Eli Lilly Company Details

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Pharmaceuticals for Women's Health Product

Table 75. Eli Lilly Revenue (2020-2025) & (US$ Million)

Table 76. Eli Lilly Recent Development

Table 77. Pfizer Company Details

Table 78. Pfizer Business Overview

Table 79. Pfizer Pharmaceuticals for Women's Health Product

Table 80. Pfizer Revenue (2020-2025) & (US$ Million)

Table 81. Pfizer Recent Development

Table 82. AbbVie Company Details

Table 83. AbbVie Business Overview

Table 84. AbbVie Pharmaceuticals for Women's Health Product

Table 85. AbbVie Revenue (2020-2025) & (US$ Million)

Table 86. AbbVie Recent Development

Table 87. Abbott Company Details

Table 88. Abbott Business Overview

Table 89. Abbott Pharmaceuticals for Women's Health Product

Table 90. Abbott Revenue (2020-2025) & (US$ Million)

Table 91. Abbott Recent Development

Table 92. Theramex Company Details

Table 93. Theramex Business Overview

Table 94. Theramex Pharmaceuticals for Women's Health Product

Table 95. Theramex Revenue (2020-2025) & (US$ Million)

Table 96. Theramex Recent Development

Table 97. Livzon Pharmaceuticals Company Details

Table 98. Livzon Pharmaceuticals Business Overview

Table 99. Livzon Pharmaceuticals Pharmaceuticals for Women's Health Product

Table 100. Livzon Pharmaceuticals Revenue (2020-2025) & (US$ Million)

Table 101. Livzon Pharmaceuticals Recent Development

Table 102. Foundation Consumer Healthcare Company Details

Table 103. Foundation Consumer Healthcare Business Overview

Table 104. Foundation Consumer Healthcare Pharmaceuticals for Women's Health Product

Table 105. Foundation Consumer Healthcare Revenue (2020-2025) & (US$ Million)

Table 106. Foundation Consumer Healthcare Recent Development

Table 107. Xianjun Pharmaceuticals Company Details

Table 108. Xianjun Pharmaceuticals Business Overview

Table 109. Xianjun Pharmaceuticals Pharmaceuticals for Women's Health Product

Table 110. Xianjun Pharmaceuticals Revenue (2020-2025) & (US$ Million)

Table 111. Xianjun Pharmaceuticals Recent Development

Table 112. Zizhu Pharmaceuticals Company Details

Table 113. Zizhu Pharmaceuticals Business Overview

Table 114. Zizhu Pharmaceuticals Pharmaceuticals for Women's Health Product

Table 115. Zizhu Pharmaceuticals Revenue (2020-2025) & (US$ Million)

Table 116. Zizhu Pharmaceuticals Recent Development

Table 117. Qianjin Pharmaceuticals Company Details

Table 118. Qianjin Pharmaceuticals Business Overview

Table 119. Qianjin Pharmaceuticals Pharmaceuticals for Women's Health Product

Table 120. Qianjin Pharmaceuticals Revenue (2020-2025) & (US$ Million)

Table 121. Qianjin Pharmaceuticals Recent Development

Table 122. Organon Pharma Company Details

Table 123. Organon Pharma Business Overview

Table 124. Organon Pharma Pharmaceuticals for Women's Health Product

Table 125. Organon Pharma Revenue (2020-2025) & (US$ Million)

Table 126. Organon Pharma Recent Development

Table 127. Insud Pharma Company Details

Table 128. Insud Pharma Business Overview

Table 129. Insud Pharma Pharmaceuticals for Women's Health Product

Table 130. Insud Pharma Revenue (2020-2025) & (US$ Million)

Table 131. Insud Pharma Recent Development

Table 132. Viatris Company Details

Table 133. Viatris Business Overview

Table 134. Viatris Pharmaceuticals for Women's Health Product

Table 135. Viatris Revenue (2020-2025) & (US$ Million)

Table 136. Viatris Recent Development

Table 137. Teva Company Details

Table 138. Teva Business Overview

Table 139. Teva Pharmaceuticals for Women's Health Product

Table 140. Teva Revenue (2020-2025) & (US$ Million)

Table 141. Teva Recent Development

Table 142. Hisamitsu Company Details

Table 143. Hisamitsu Business Overview

Table 144. Hisamitsu Pharmaceuticals for Women's Health Product

Table 145. Hisamitsu Revenue (2020-2025) & (US$ Million)

Table 146. Hisamitsu Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Pharmaceuticals for Women's Health Market Share by Type: 2024 VS 2031

Figure 3. Oral Features

Figure 4. Topical Features

Figure 5. Global Pharmaceuticals for Women's Health Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Global Pharmaceuticals for Women's Health Market Share by Application: 2024 VS 2031

Figure 7. Postmenopausal Osteoporosis Case Studies

Figure 8. Endometriosis Case Studies

Figure 9. Polycystic Ovarian Syndrome Case Studies

Figure 10. Pregnancy Disorders Case Studies

Figure 11. Others Case Studies

Figure 12. Pharmaceuticals for Women's Health Report Years Considered

Figure 13. Global Pharmaceuticals for Women's Health Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Pharmaceuticals for Women's Health Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Pharmaceuticals for Women's Health Market Share by Region: 2024 VS 2031

Figure 16. Global Pharmaceuticals for Women's Health Market Share by Players in 2024

Figure 17. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals for Women's Health as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Pharmaceuticals for Women's Health Revenue in 2024

Figure 19. North America Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Pharmaceuticals for Women's Health Market Share by Type (2020-2031)

Figure 21. North America Pharmaceuticals for Women's Health Market Share by Application (2020-2031)

Figure 22. North America Pharmaceuticals for Women's Health Market Share by Country (2020-2031)

Figure 23. United States Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Pharmaceuticals for Women's Health Market Share by Type (2020-2031)

Figure 27. Europe Pharmaceuticals for Women's Health Market Share by Application (2020-2031)

Figure 28. Europe Pharmaceuticals for Women's Health Market Share by Country (2020-2031)

Figure 29. Germany Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. China Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. China Pharmaceuticals for Women's Health Market Share by Type (2020-2031)

Figure 37. China Pharmaceuticals for Women's Health Market Share by Application (2020-2031)

Figure 38. Asia Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia Pharmaceuticals for Women's Health Market Share by Type (2020-2031)

Figure 40. Asia Pharmaceuticals for Women's Health Market Share by Application (2020-2031)

Figure 41. Asia Pharmaceuticals for Women's Health Market Share by Region (2020-2031)

Figure 42. Japan Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. South Korea Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. China Taiwan Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Share by Type (2020-2031)

Figure 50. Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Share by Application (2020-2031)

Figure 51. Middle East, Africa, and Latin America Pharmaceuticals for Women's Health Market Share by Country (2020-2031)

Figure 52. Brazil Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Mexico Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Turkey Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Israel Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. GCC Countries Pharmaceuticals for Women's Health Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Amgen Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 59. Bayer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 60. Merck KGaA Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 61. Merck & Co Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 62. Ferring Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 63. Eli Lilly Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 64. Pfizer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 65. AbbVie Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 66. Abbott Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 67. Theramex Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 68. Livzon Pharmaceuticals Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 69. Foundation Consumer Healthcare Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 70. Xianjun Pharmaceuticals Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 71. Zizhu Pharmaceuticals Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 72. Qianjin Pharmaceuticals Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 73. Organon Pharma Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 74. Insud Pharma Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 75. Viatris Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 76. Teva Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 77. Hisamitsu Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2020-2025)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed